Time and materials award provide project manager support services for the generic drug program; services to provide research and regulatory health project management support for the generic drug…
Ended Awarded Last action
- Contract number
- 75F40120F19131
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,187,302
Award facts
- Contract value 100% obligated
- $2,187,301.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Rockville, MD 20857, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$171,313 | |
| Additional Work (new agreement, FAR part 6 applies) | $163,460 | |
| Funding Only Action | $150,135 | |
| Funding Only Action | $307,308 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $616,724 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $605,260 | |
| Exercise an Option | $145,013 | |
| Original award | $370,716 |
About this award
This is a time and materials award to Brillient Corporation, a minority-owned small business, to provide project management support services for the Food and Drug Administration's (FDA) Generic Drug User Fee Amendments (GDUFA) program. The $2,187,301.62 award is a call against the Professional Services Schedule (PSS) contract vehicle, which is a multiple-award government-wide acquisition contract managed by the General Services Administration (GSA). The services will support the FDA's regulatory science and generic drug program efforts. This contract award does not have a set-aside designation.
Description
Time and materials award provide project manager support services for the generic drug program; services to provide research and regulatory health project management support for the generic drug user fee amendments (gdufa)- funded regulatory science
Quick answers
Who was awarded contract 75F40120F19131?
75F40120F19131 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on July 14, 2020.
How much is contract 75F40120F19131 worth?
The government has obligated $2,187,302 on 75F40120F19131.
Is contract 75F40120F19131 an order under another contract?
Yes. 75F40120F19131 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40120F19131 competed?
The extent of competition for 75F40120F19131 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award